Template:SubstanceBox/Gabapentin: Difference between revisions

>Graham
m wiki ref formatting
>Isaak
Annotate bioavailability correctly
 
Line 54: Line 54:
     |OralROA_Collapsed=false
     |OralROA_Collapsed=false
     |OralROA_Caption=
     |OralROA_Caption=
     |OralROA_Bioavailability=27% - 60%<ref name="NeurotoninMedScape">{{Citation | title=Neurontin, Gralise (gabapentin) dosing, indications, interactions, adverse effects, and more | url=https://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011}}</ref>
     |OralROA_Bioavailability=[[Oral min bioavailability::27]]% - [[Oral max bioavailability::60]]%<ref name="NeurotoninMedScape">{{Citation | title=Neurontin, Gralise (gabapentin) dosing, indications, interactions, adverse effects, and more | url=https://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011}}</ref>
     |OralROA_Threshold=[[Oral threshold dose::200]] [[Oral dose units::mg]]
     |OralROA_Threshold=[[Oral threshold dose::200]] [[Oral dose units::mg]]
     |OralROA_Light=[[Oral min light dose::200]] - [[Oral max light dose::900]] mg
     |OralROA_Light=[[Oral min light dose::200]] - [[Oral max light dose::900]] mg